Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: Normal contrast medium enhancement and cyclical-phase dependency

Radiology

Volumn 203, Issue 1, 1997, Pages 137-144

  Kuhl, Christiane K ^a   Bieling, Heribert B ^a   Gieseke, Jürgen ^b   Kreft, Burkhard P ^a   Sommer, Torsten ^a   Lutterbey, Götz ^a   Schild, Hans H ^a  

^a UNIVERSITY OF BONN   (Germany)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

Breast neoplasms, diagnosis; Breast, MR; Magnetic resonance (MR), contrast enhancement; Menstruation

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; ARTICLE; BREAST TUMOR; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR DIAGNOSIS; TUMOR VOLUME;

EID: 0030934413     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.203.1.9122382     Document Type: Article

References (35)

1. Aoki S, Sakamoto T, Koutake H, Tanaka T, Murata K, Morita R. Dynamic MR mammography: value of imaging during the first minute (abstr). Radiology 1993; 189(P):105.
2. Fischer U, Van Heyden D, Vosshenrich R, Vieweg I, Grabbe E. Signalverhalten maligner und benigner läsionen in der dynamischen 2D-MRT der mamma. Fortschr Röntgenstr 1993; 158:287-292. [German]
3. Heywang SH. Contrast enhanced magnetic resonance imaging of the breast. Invest Radiol 1994; 29:94-104.
4. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA: preliminary observations. Radiology 1989; 170:681-686.
5. Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995; 196:115-122.
6. Flickinger FW, Allison JD, Sherry RM, Wright JC. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. Magn Reson Imaging 1993; 11:617-620.
7. Gribbestad IS, Nilsen G, Fjøsne HE, Kvinnsland S, Haugen OA, Rinck PA. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography. JMRI 1994; 6:477-480.
8. Heywang SH, Wolf A, Pruss E, Hilbertz T, Eiermann W, Permanetter W. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989; 171:95-103.
9. Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT. Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 1990; 174:491-494.
10. Fobben ES, Zubin CZ, Kalisher L, Dembner AG, Seltzer MH, Santoro EJ. Breast MR imaging with commercially available techniques: radiologic-pathologic correlation. Radiology 1995; 196:143-152.
11. Bieling HB, Kuhl CK, Schild H. Application of a micro-computer based diagnosis system improves diagnostic accuracy and reduces costs of dynamic MR mammography (abstr). Eur Radiol 1995; 5(suppl):405.
12. Gilles R, Guinebretière JM, Shapeero LG, et al. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients. Radiology 1993; 188:473-478.
13. Heywang SH, Hilbertz T, Beck R, Bauer WM, Eiermann W, Permanetter W. Gd-DTPA enhanced MR imaging of the breast in patients with postoperative scarring and silicon implants. J Comput Assist Tomogr 1990; 14:348-349.
14. Lewis Jones HG, Whitehouse GH, Leinster SJ. The role of magnetic resonance imaging in the assessment of local recurrent breast carcinoma. Clin Radiol 1991; 43:197-204.
15. Dao TH, Rahmouni A, Campana F, Láurent M, Asselain B, Fourquet A. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 1993; 187:751-755.
16. Kaiser WA, Deimling M. Eine neue multischicht-meßsequenz für die komplette dynamische MR-untersuchung an größeren Organen: anwendung an der brust. Fortschr Röntgenstr 1990; 152:577-582. [German]
17. Fischer U, Brinck U, Vosshenrich R, et al. Accuracy of MR mammography in ductal carcinoma in situ (abstr). Radiology 1995; 197(P):129.
18. Vogel PM, Georgiade NG, Fetter BF, et al. The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol 1981; 104:23-24.
19. Christov K, Chew KL, Ljung BM, et al. Proliferation of normal breast epithelial cells as shown by in vivo labeling with bromodeoxyuridine. Am J Pathol 1991; 138: 1371-1377.
20. Longacre TA, Bartow SA. A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 1986; 10:382-393.
21. Malberger E, Gutterman E, Bartfeld E, Zajicek G. Cellular changes in the mammary gland epithelium during the menstrual cycle: a computer image analysis study. Acta Cytol 1987; 31:305-308.
22. Meyer F, Brisson J, Morrison AS, Brown JB. Endogenous sex hormones, prolactin, and mammographic features of breast tissue in premenopausal women. J Natl Cancer Inst 1986; 77:617-620.
23. Meyer F, Brown JB, Morrison AS, MacMahon B. Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. J Natl Cancer Inst 1986; 77:613-616.
24. Nelson TR, Pretorius DH, Schiffer LM. Menstrual variation of normal breast NMR relaxation parameters. J Comput Assist Tomogr 1985; 9:875-879.
25. Fowler PA, Casey CE, Cameron GG, Foster MA, Knight CH. Cyclic changes in composition and volume of the breast during the menstrual cycle, measured by magnetic resonance imaging. Br J Obstet Gynecol 1990; 97:595-602.
26. Martin B, el Yousef SJ. Transverse relaxation time values in MR imaging of normal breast during menstrual cycle. J Comput Assist Tomogr 1986; 10:924-927.
27. Saad Z, Vincent M, Bramwell V, et al. Timing of surgery influences survival in receptor-negative as well as receptor-positive breast cancer. Eur J Cancer 1994; 30: 1348-1352.
28. Senie RT, Kinne DW. Menstrual timing of treatment for breast cancer. Monogr Natl Cancer Inst 1994; 16:85-90.
29. Zeppa R. Vascular response of the breast to estrogen. J Clin Endocrinol Metab 1969; 29:695-700.
30. Hankey BF, Brinton LA, Kessler LF, et al. Breast. In: Miller BA, Ries LAG, Hankey BF, et al, eds. SEER cancer statistics review 1973-1990. National Institutes of Health publication no. 94-2789. Bethesda, Md: U.S. Department of Health and Human Services National Cancer Institute, 1993; 1.
31. Kaiser WA, Mittelmeier O. MR-mammographie bei risikopatientinnen. Fortschr Röntgenstr 1992; 156:576-581. [German]
32. Fischer U, Vosshenrich R, Keating D, et al. MR-guided biopsy of suspect breast lesions with a simple stereotaxic add-on device for surface coils. Radiology 1994; 192:272-273.
33. Heywang-Köbrunner SH, Huynh AT, Viehweg P, Hanke W, Requard H, Paprosch I. Prototype of a breast coil for MR-guided needle localization. J Comput Assist Tomogr 1994; 18:876-881.
34. Orel SG, Schnall MD, Newman RW, Powell CM, Torosian MH, Rosario EF. MR-imaging-guided localization and biopsy of breast lesions: initial experience. Radiology 1994; 193:97-102.
35. Elevelt A, Kuhl CK, Selder B, Gieseke J. A new breast biopsy and localizer device designed for MR-guided interventional procedures (abstr). In: Proceedings of the International Society of Magnetic Resonance in Medicine 1995. Berkeley, Calif: International Society of Magnetic Resonance in Medicine, 1995; 1:146.